Protagonist Therapeutics shares owned by Duquesne Family Office
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Duquesne Family Office
from 13F filings
Historical chart of Duquesne Family Office investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by Duquesne Family Office
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $11M | 160k | 66.43 |